• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Ultra-high-performance liquid chromatography for the determination of exenatide in monkey plasma by tandem quadrupole mass spectrometry

    2013-12-23 06:14:52JinFengZhngChunJieShYuSunYunYunGiJiYeSunJingBinHnXinShoChunShYouXinLiWnHuiLiu
    Journal of Pharmaceutical Analysis 2013年4期

    Jin-Feng Zhng, Chun-Jie Sh, Yu Sun, Yun-Yun Gi, Ji-Ye Sun,Jing-Bin Hn, Xin Sho, Chun-N Sh, You-Xin Li, Wn-Hui Liu,,*

    aSchool of Pharmacy, Yantai University, Yantai 264003, PR China

    bState Key Laboratory of Long-acting and Targeting Drug Delivery System, Shandong Luye Pharmaceutical Co. Ltd.,Yantai 264003, PR China

    cRushan People's Hospital, Weihai 264200, PR China

    1. Introduction

    There has been an increasing incidence of type 2 diabetes in the world population recently. The use of traditional therapies for type 2 diabetes to achieve adequate glycaemic control was often limited by undesired hypoglycemic and weight gain. Moreover, it has been witnessed that sustained development of antidiabetic therapies exploits the enteroinsular axis. Exenatide (synthetic exendin-4), a human glucagon-like peptide-1 (GLP-1) analogue with a molecular weight of 4186.6 Da, is the first member of the class of GLP-1 receptor agonists [1-4]. It mimics the action of the human hormone GLP-1 that plays a major role in the maintenance of glucose homoeostasis [5], which could improve the glycaemic control through enhancing the glucose-dependent insulin secretion, suppressing the inappropriately elevated postprandial glucagon secretion, slowing the gastric emptying, and reducing the food intake with the result of bodyweight reducing [6,7].

    Exenatide has a longer half-life (about 2.4 h) than GLP-1(less than 2 min) with no rebound effect until the termination of administration. The clinical use of exenatide still requires daily (two times a day) repeated subcutaneous injections.Recently, a slow release form of exenatide has been investigated that only requires weekly intramuscular injections,which exhibits good acceptability and compliance in clinical use [8].

    To date, various methods have been developed for the quantitation of exenatide,such as immunoassay(ELISA)[8,9]and high-performance liquid chromatographic-tandem mass spectrometry (HPLC/MS/MS) method [10,11]. However, analytical ranges used in ELISA are typically limited to one to two orders of magnitude. And sometimes ELISA has poor repeatability and specificity [12]. The immunoassay methodologies also have potential interferences from endogenous compounds and require expensive antibodies and special reagents that are often difficult to obtain, which significantly lengthens the method development time and increases the cost of the experiment [11]. Compared with immunoassay methodologies, the method of UPLC/MS/MS for peptide quantitative research is potential and worthy of further exploration.The previous HPLC/MS/MS method for exenatide has a linear calibration range of 20-2000 ng/mL requiring 150 μL of blood plasma [10], although its lower limit of quantitation(LLOQ) was limited to quantitate the effective concentration of pharmacology.

    Therefore, in the present study,we investigated a rapid and sensitive UPLC/MS/MS method for the determination of exenatide levels in monkey plasma and applied this method to the evaluation of Byetta after the subcutaneous injection of 5 μg for each animal. For the first time, the UPLC/MS/MS method is performed for the determination of the plasma concentration of exenatide with lower LLOQ (0.10 ng/mL),which has great future potential to be used for the monkey and human pharmacokinetics study.

    2. Experimental

    2.1. Reagents and chemicals

    Exenatide (purity>97%) was supplied by BACHEM, Inc(Torrance, USA). Bivalirudin (purity>87%) for using as the internal standard (IS) was purchased from Shanghai TASH Biotechnology Co., Ltd. Methanol and acetonitrile are HPLC grade, purchased from Merck KGaA. Formic acid (~98%)was purchased from Fluka (Buchs, Switzerland). Ammonium hydroxide (25.0-28.0%) was purchased from LaiYang ShuangXing Chemical Co., Ltd (Shandong, China). Oasis?MCX (30 mg, 1 cc) was purchased from Waters Corporation(Milford, MA, USA). Deionized (DI) water was generated from Milli-Q water purifying system purchased from Millipore Corporation (MA, USA).

    2.2. Instrumentation and chromatographic conditions

    The UPLC/MS/MS system consisted of an Agilent 1290 series HPLC system (Agilent Technologies, Palo Alto, CA, USA)coupled to an Applied Biosystems Sciex Qtrap 5500 mass spectrometer (Applied Biosystems Sciex, Ontario, Canada)using electrospray ionization (ESI). Chromatography was performed on a ZORBAX RRHD Eclipse Plus C18 (1.8 μm,50 mm×2.1 mm)maintained at 40°C using a gradient elution with 0.2%formic acid as solvent A and methanol as solvent B.The gradient involved: 10% B for 1.5 min; a linear increase from 10% to 90% B in 1.0 min, 90% B for 0.5 min; a linear decrease from 90% to 10% B in 0.1 min; and equilibration at 10% B for 2.0 min. The flow rate was 0.5 mL/min without a split.

    Multiple reaction monitoring (MRM) at unit resolution involved transitions of the protonated forms of exenatide at m/z 1047.4→396.3 and of bivalirudin at m/z 1090.7→650.3 in the positive ion mode. Full-scan product ion mass spectra of exenatide and bivalirudin are shown in Fig.1. Optimized MS conditions were described as follows: curtain gas, gas 1 and gas 2(all nitrogen)with 35,55 and 55 units,respectively;dwell time with 100 ms; ion spray voltage with 5500 V; source temperature with 575°C; declustering potentials with 240 V for exenatide and 100 V for bivalirudin;collision energies with 42 eV (m/z 1047.4→396.3) for exenatide and 48 eV for bivalirudin (m/z 1090.7→650.3).

    2.3. Preparation of calibration standards and quality control(QC) samples

    Fig.1 The product ion scans of[M+4H]4+for exenatide(A)and[M+2H]2+ for bivalirudin (B).

    A stock solution of exenatide (1.0 mg/mL) in methanol(containing 0.1% formic acid) was diluted with methanol/Milli-Q water/0.1% formic acid (90:10:0.1, v/v/v) to give a series of standard solutions. A series of calibration standards were then prepared by spiking blank monkey plasma samples(50 μL) with 50 μL aliquots of standard solutions to give exenatide concentrations in plasma of 0.10,0.30,0.50,1.0,3.0,10 and 30 ng/mL, respectively. Quality control (QC) samples at three concentrations (0.20, 2.0 and 24 ng/mL) were prepared independently by the same procedure.Stock solution of the internal standard (IS, bivalirudin; 1.0 mg/mL) was also prepared in methanol (containing 0.1% formic acid).A working IS solution (bivalirudin, 8.5 ng/mL) was obtained by dilution of the bivalirudin stock solution with methanol/Milli-Q water/0.1% formic acid (90:10:0.1, v/v/v).

    2.4. Sample preparation

    All frozen monkey plasma samples were thawed at room temperature and subjected to SPE as follows. An aliquot of 50 μL plasma, 50 μL methanol/Milli-Q water/0.1% formic acid(90:10:0.1,v/v/v)and 50 μL IS solution were added in the 1.5 mL Eppendorf tube. The mixture was vortex-mixed for 1 min and then centrifugated at 15000×g for 5 min. After precondition of 1 mL of methanol and 0.5 mL of formic acid (0.5%) in Milli-Q water, the supernatant was transferred to the Oasis?MCX. The columns were washed with 0.5%formic acid in Milli-Q water,and then methanol/2% aqueous formic acid 96:4 (v/v). The analyte and IS were eluted with two 200 μL portions of acetonitrile/methanol/Milli-Q water/25% aqueous ammonium hydroxide(4:1:1:1.0, v/v/v/v) to 10 mL plastic tube. The collection was added with 200 μL acetonitrile/methanol/Milli-Q water/formic acid (6:5:1:0.1, v/v/v/v), and then evaporated to dryness at 50°C under a gentle stream of nitrogen.The sample was reconstituted in 50 μL methanol/water/0.1% formic acid (90:10:0.1, v/v/v) and vortexed for 30 s. A 10 μL aliquot of the sample solution was injected into the UPLC/MS/MS system.

    2.5. Method validation

    Assay validation was performed according to the FDA guidelines [13]. Specificity was performed by analyzing blank plasma samples from six different subjects.Three independent standard curves and six replicates of low, medium and high QC samples were analyzed on three different days. Linearity was analyzed by weighted linear regression (1/x2) of analyteinternal standard peak area ratios. The precision (represented by the relative standard deviation, RSD) and the accuracy(represented by the relative error, RE) were evaluated based on assay of the LLOQ, QC samples in three consecutive days,six replicates for each day. Recovery was determined by comparing peak areas of QC samples with those of postextraction spiked blank plasma. Matrix effects were evaluated by comparing peak areas of the analyte in QC post-extraction spiked blank plasma samples with those in standard solutions.

    Stability tests were conducted to evaluate the analyte stability in stock solutions and in plasma samples under different conditions. Stock solution stability was determined by the area response of analyte (at -40°C) and internal standard(at 4°C)in the stability samples with that comparing of samples prepared from fresh stock solution. Room temperature stability(2 h),processed samples stability(reinjection stability at room temperature for 12 h), freeze-thaw stability(three cycles), long-term stability at -40°C (1 month) were performed at QC samples using three replicates at each level.Samples were considered to be stable if assay values were within the acceptable limits of accuracy (±15% SD) and precision (≤15% RSD).

    2.6. Application of the method to a pharmacokinetic study in monkey

    Animal studies were all performed under the instruction of protocols required by the Animal Care and Use Committee of the Chinese Academy of Medical Sciences.

    The experiment was led by West China Hai-Qi Medical Technology Co., Ltd. Three male healthy monkeys (3.5-4.0 kg)were given subcutaneous injection of the same dose of Byetta(5 μg for each monkey). Blood samples (0.5 mL at each time point) were collected from the hind limbs vein prior to dosing and at 5 min, 15 min, 30 min, 1 h, 2 h, 4 h, 6 h, 8 h, 12 h and 24 h after dosing. Blood samples were centrifuged and plasma was separated and stored at -40°C until analysis. The plasma concentration-time profiles for exenatide in each subject were analyzed by noncompartmental analysis using DAS 2.1.

    3. Results and discussion

    3.1. Mass spectrometry

    The [M+4H]4+of exenatide was selected as the precursor ion(m/z 1047.4) because it was the principal charged species observed in the Q1 scan process. The corresponding[M+2H]2+of bivalirudin (m/z 1090.7) was chosen for the same reason. Accordingly, the transition m/z 1047.4→396.3 was selected as quantifier. The transition m/z 1090.7→650.3 was used to bivalirudin.

    3.2. Method development

    Various mobile phase combinations of acetonitrile, methanol,ammonium acetate and formic acid were investigated to optimize the chromatography for sensitivity, speed and peak shape.Methanol gave a better response than acetonitrile and the peak shape was improved by the addition of formic acid. The ZORBAX RRHD Eclipse Plus C18(1.8 μm, 50 mm×2.1 mm)was chosen because it gave the best resolution and peak shapes with minimal matrix effects.At the same time,we found that the dilution of exenatide had a great effect on the signal intensity and that the acidity of the dilution gave great contribution to the stability of exenatide. The dilution was finally confirmed as the methanol/Milli-Q water/0.1% formic acid (90:10:0.1, v/v/v).

    Isolation of exenatide from plasma is a tedious task,because of the low concentration levels and interferences induced by matrix. The result of protein precipitation was not comforting [14], which should be related to the relatively big size of the peptide drug that leads to the co-precipitation of exenatide. The recovery of reverse phase liquid-liquid extraction was low, which might be due to the related properties of amphoteric compound.According to the information,various solid-phase extractions (Waters Oasis?HLB, Waters Oasis?MCX, Waters Oasis?WAX) were investigated. Sample prepared by HLB and WAX showed the poor recovery.Oasis?MCX with appropriate condition of elution provided better recovery and less remaining endogenous interferences.The percentage of formic and aqueous ammonium in the elutions was a key factor.Glass tube and plastic tube were also investigated as the receiving vessel, and the results indicated that the glass tube had high adsorption of exenatide.It should be suggested that exenatide contained more acidic amino acids leading to the more easily glass adsorption [15,16].

    A number of potential internal standards including triptorelin, elcatonin, and diazepam were evaluated in the present study, while most of them were incompatible with the sample preparation procedure because of their physicochemical properties.Finally,bivalirudin was chosen for the suitable IS for its similar physicochemical characteristics and similar retention time. It could be presumed that bivalirudin and exenatide had more acidic amino acid than basic amino acid in their structures while some others went in the opposite direction.Moreover, the results of our study showed that the pH of compounds was an important factor in the complex elution systems of MCX column.

    Blank plasma of several animals including rat,dog,monkey and human were compared; however, there was no interference with the endogenous substances only in the blank monkey and human plasma as shown in Fig.2, which might be caused by the different kinds and contents of GLP-1 and its analogues in various species plasma.

    3.3. Method validation

    3.3.1. Selectivity and chromatography

    The assay was found to be highly specific since there were no endogenous peaks in monkey plasma at the retention times of IS and exenatide. Representative chromatograms of blank plasma and blank plasma spiked with exenatide at the LLOQ(0.10 ng/mL) were shown in Fig.3.

    3.3.2. Linearity

    Calibration curves were prepared using seven standards,and it was linear in the range of 0.10-30 ng/mL. The mean correlation coefficient (r2) was greater than 0.9986 for all curves.

    3.3.3. Precision and accuracy

    As shown in Table 1, the precision and accuracy of exenatide in the intra- and inter-day runs were within ±15% at LOQ,MOQ, and HOQ concentrations and within ±20% at LLOQ QCs.

    3.3.4. Extraction efficiency

    The recoveries of exenatide and the IS were good and reproducible. Recoveries of exenatide from the low, medium and high QC samples were 65±2%, 63±3% and 63 ±3%, respectively. The recovery of bivalirudin was 69 ± 4%.

    Fig.2 Representative MRM chromatograms of exenatide(m/z 1047.4→396.3)in four different animals blank plasma(human,monkey,dog and rat).

    Fig.3 Representative MRM chromatograms of exenatide and bivalirudin in monkey plasma. (A) Blank plasma; (B) blank plasma spiked with 0.1 ng/mL of exenatide (I) and 8.5 ng/mL bivalirudin (II); (C) plasma sample from a monkey volunteer 15 min of exenatide after the subcutaneous injection of exenatide (5 μg for each monkey).

    Table 1 Precision and accuracy for the determination of exenatide in monkey plasma (data are based on assay of six replicates on three different days).

    3.3.5. Matrix effect

    The matrix effects were shown to be minimal based on the ratios of the peak areas for exenatide in the low, medium and high post-extraction spiked blank plasma samples to the peak areas in the corresponding standard solutions; these ratios were 106±4%, 104±7% and 105±2%,respectively. Similarly the ratio of bivalirudin was 105± 8%.

    3.3.6. Stability

    The stock solutions of exenatide were stable at -40°C for at least one month and IS solutions were stable at 4°C for at least three months.

    Room temperature stability, reinjection stability, freezethaw stability and long-term stability for exenatide were investigated at the low, medium and high QC samples. The results revealed that exenatide was stable under all of the conditions examined (Table 2).

    3.4. Pharmacokinetic study

    The mean concentration-time profile of exenatide after the subcutaneous injection of exenatide is shown in Fig.4. The mean peak plasma concentration (Cmax) was 2.1±0.4 ng/mL at a time(Tmax)of 0.5 h after the injection was given.The mean area under the plasma concentration-time curve (AUC0-t) was 5.1±0.7 ng ·h/mL and the mean elimination half-life(t1/2)was 1.2±0.2h.

    4. Conclusion

    In summary, a highly sensitive and selective UPLC/MS/MS method was first developed for the determination of exenatide in monkey plasma, which had the LLOQ of 0.10 ng/mL and good accuracy and precision. The lower requirement ofmonkey plasma volume was only 50 μL, which provided the possibility for repeated analyses without increasing blood volumes. Because there was also no interference with the endogenous substances in human plasma, this method could be well applicable to the clinical pharmacokinetic research.

    Table 2 Stability of exenatide under various conditions (data are mean±SD of three replicates).

    Fig.4 Plasma concentration-time profile of subcutaneous injection of exenatide(5 μg for each monkey)to healthy monkey.Data are mean±SD for three monkeys (three males).

    This work was supported by the National Basic Research Program of China (973 Program) (No. 2010CB735602 and No. 2012CB724003). We also would like to thank Taishan Scholar Projects for their kindly supported in the method development.

    [1] P.R. Flatt, C.J. Bailey, B.D. Green, Recent advances in antidiabetic drug therapies targeting the enteroinsular axis, Curr. Drug Metab. 10 (2009) 125-137.

    [2] B.T. Srinivasan, J. Jarvis, K. Khunti, et al., Recent advances in the management of type 2 diabetes mellitus: a review, Postgrad.Med. J. 84 (2008) 525-526.

    [3] J.S. Freeman, A physiologic and pharmacological basis for implementation of incretin hormones in the treatment of type 2 diabetes mellitus, Mayo. Clin. Proc. 85 (12) (2010) 7-9.

    [4] V.R. Aroda, R. Ratner, The safety and tolerability of GLP-1 receptor agonists in the treatment of type 2 diabetes: a review,Diabetes Metab. Res. Rev 27 (2011) 528-529.

    [5] R. Jones, The safety and tolerability of GLP-1 receptor agonists in the treatment of type-2 diabetes, Int. J. Clin. Pract. 64 (2010)1403-1414.

    [6] P.A. Kothare, H. Linnebjerg, Y. Isaka, et al., Pharmacokinetics,pharmacodynamics, tolerability, and safety of exenatide in Japanese patients with type 2 diabetes mellitus, J. Clin. Pharmacol. 48 (2008) 1390.

    [7] D.P. Bradley, R. Kulstad, D.A. Schoeller, Exenatide and weight loss, Nutrition 26 (2010) 245-247.

    [8] M. Fineman, S. Flanagan, K. Taylor, et al., Pharmacokinetics and pharmacodynamics of exenatide extended-release after single and multiple dosing, Clin. Pharmacokinet. 50 (1) (2011) 69-72.

    [9] K. Kristen M, The current status of exenatide once weekly, Clin.Med. Insights: Ther. 3 (2011) 223-224.

    [10] J.R.Kehler,C.L.Bowen,S.L.Boram,et al.,Application of DBS for quantitative assessment of the peptide Exendin-4;comparison of plasma and DBS method by UPLC-MS/MS, Bioanalysis 2 (8)(2010) 1461-1464.

    [11] L. Dillen, W. Cools, L. Vereyken, et al., Comparison of triple quadrupole and high-resolution TOF-MS for quantification of peptides, Bioanalysis 4 (5) (2012) 566-575.

    [12] A.N. Hoofnaqle, M.H. Wener, The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry, J. Immunol. Methods 34 (1-2) (2009) 3-11.

    [13] Guidance for Industry Bioanalytical Method Validation,U.S.Departmentof Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research(CDER), Center for Veterinary Medicine(CVM), BP, May 2001〈http://www.fda.gov/cder/guidance/4252fnl.htm〉.

    [14] R.W.Zhang,W.T.Liu,L.L.Geng,et al.,Quantitative analysis of a novel antimicrobial peptide in rat plasma by ultra performance liquid chromatography-tandem mass spectrometry, J. Pharm.Anal. 1 (3) (2011) 192.

    [15] I.D.V. Broek, R.W. Sparidans, J.H.M. Schellens, et al., Quantitative bioanalysis of peptides by liquid chromatography coupled to(tandem)mass spectrometry,J.Chromatogr.B 872(2008)1-7.

    [16] K. Heining, T. Wirz, Determination of taspoglutide in human and animal plasma using liquid chromatography-tandem mass spectrometry with orthogonal column-switching, Anal. Chem. 81(2009) 3705-3711.

    真人做人爱边吃奶动态| 少妇人妻精品综合一区二区 | 91精品国产九色| 深爱激情五月婷婷| avwww免费| 美女免费视频网站| 亚洲av.av天堂| a级毛片免费高清观看在线播放| 欧美激情在线99| 亚洲av第一区精品v没综合| 在线观看午夜福利视频| 最后的刺客免费高清国语| 可以在线观看的亚洲视频| 亚洲欧美日韩卡通动漫| 免费观看人在逋| 亚洲婷婷狠狠爱综合网| 丰满人妻一区二区三区视频av| 国产精品一区二区三区四区久久| 露出奶头的视频| 日日摸夜夜添夜夜爱| 亚洲最大成人手机在线| 丝袜美腿在线中文| 亚洲经典国产精华液单| 精品福利观看| 日本黄大片高清| 全区人妻精品视频| 网址你懂的国产日韩在线| 午夜福利高清视频| 久久久成人免费电影| 成人漫画全彩无遮挡| 欧美成人a在线观看| 中文字幕精品亚洲无线码一区| 男人狂女人下面高潮的视频| 久久久精品大字幕| 97超碰精品成人国产| 国产探花极品一区二区| 搡老熟女国产l中国老女人| 在线播放无遮挡| 国产女主播在线喷水免费视频网站 | 国内少妇人妻偷人精品xxx网站| 国产精品亚洲一级av第二区| 亚洲中文字幕日韩| 三级国产精品欧美在线观看| 日本黄大片高清| 精品久久久久久久久亚洲| 免费看a级黄色片| 日本-黄色视频高清免费观看| 99久久成人亚洲精品观看| 天堂网av新在线| 精品久久久噜噜| 国产片特级美女逼逼视频| 天堂√8在线中文| 久久久成人免费电影| 亚洲国产欧美人成| videossex国产| 久久久色成人| 欧美成人免费av一区二区三区| 国产高清三级在线| 久久久久国产网址| 婷婷精品国产亚洲av在线| 2021天堂中文幕一二区在线观| avwww免费| 亚洲国产欧洲综合997久久,| 最近视频中文字幕2019在线8| 久久天躁狠狠躁夜夜2o2o| 精品欧美国产一区二区三| 99国产精品一区二区蜜桃av| 亚洲七黄色美女视频| 精品人妻熟女av久视频| 六月丁香七月| 亚洲精品影视一区二区三区av| 亚洲精品影视一区二区三区av| 最近在线观看免费完整版| 久久精品国产亚洲网站| 麻豆乱淫一区二区| 久久人人爽人人片av| 国产 一区 欧美 日韩| 高清毛片免费看| 国产欧美日韩精品一区二区| 欧美国产日韩亚洲一区| 久久99热这里只有精品18| 日韩欧美精品v在线| 久久精品夜夜夜夜夜久久蜜豆| 无遮挡黄片免费观看| 国产精品一及| 哪里可以看免费的av片| 嫩草影院精品99| av.在线天堂| 国产三级中文精品| 一区福利在线观看| 久久这里只有精品中国| 深夜a级毛片| 搞女人的毛片| 人人妻人人澡人人爽人人夜夜 | 在线看三级毛片| 99久久成人亚洲精品观看| 国产亚洲精品综合一区在线观看| 欧美绝顶高潮抽搐喷水| 91狼人影院| 老司机福利观看| 观看免费一级毛片| 日韩大尺度精品在线看网址| 大香蕉久久网| www日本黄色视频网| 国国产精品蜜臀av免费| 久久国内精品自在自线图片| 午夜福利成人在线免费观看| 亚洲av中文字字幕乱码综合| 黄色日韩在线| 麻豆久久精品国产亚洲av| 午夜a级毛片| 九九热线精品视视频播放| 一本久久中文字幕| 亚洲av电影不卡..在线观看| 在线国产一区二区在线| av.在线天堂| 久久亚洲精品不卡| 免费观看人在逋| 一进一出抽搐动态| 国产在线精品亚洲第一网站| 婷婷亚洲欧美| 免费看a级黄色片| 色哟哟·www| 99久久精品国产国产毛片| 欧美极品一区二区三区四区| 日韩欧美在线乱码| 国内精品美女久久久久久| 日韩欧美一区二区三区在线观看| 91久久精品国产一区二区成人| 亚洲欧美中文字幕日韩二区| 尤物成人国产欧美一区二区三区| 国产精品乱码一区二三区的特点| 国产爱豆传媒在线观看| 在线观看一区二区三区| 男女边吃奶边做爰视频| 毛片女人毛片| 又爽又黄a免费视频| 国产精品99久久久久久久久| 国产精品一区二区性色av| 久久热精品热| 色噜噜av男人的天堂激情| 一级毛片电影观看 | 亚洲欧美日韩高清专用| 免费看av在线观看网站| 国产久久久一区二区三区| 极品教师在线视频| 人人妻人人看人人澡| 99久久九九国产精品国产免费| 日本免费一区二区三区高清不卡| 日韩欧美精品v在线| 日韩av不卡免费在线播放| 天堂影院成人在线观看| 国产精品乱码一区二三区的特点| 3wmmmm亚洲av在线观看| 久久久精品欧美日韩精品| 国产亚洲精品久久久com| 亚洲国产精品久久男人天堂| 白带黄色成豆腐渣| 日本与韩国留学比较| 久久精品综合一区二区三区| 国产黄色视频一区二区在线观看 | 日日撸夜夜添| 综合色av麻豆| 亚洲高清免费不卡视频| 欧美激情在线99| 国产亚洲精品综合一区在线观看| av在线播放精品| 99国产精品一区二区蜜桃av| 99热6这里只有精品| 久久久久精品国产欧美久久久| 波多野结衣巨乳人妻| 久久精品国产亚洲av涩爱 | 亚洲在线自拍视频| 免费av观看视频| 在线观看av片永久免费下载| 久久中文看片网| 男女之事视频高清在线观看| 色视频www国产| 18+在线观看网站| 国产高清不卡午夜福利| 国产 一区精品| 亚洲av熟女| 免费看av在线观看网站| 亚洲欧美日韩东京热| 日韩中字成人| 国产一区二区三区在线臀色熟女| 久99久视频精品免费| 一级a爱片免费观看的视频| 男人舔女人下体高潮全视频| 狠狠狠狠99中文字幕| 最新在线观看一区二区三区| 国产色婷婷99| 麻豆久久精品国产亚洲av| 日韩三级伦理在线观看| videossex国产| 亚洲人成网站高清观看| 亚洲中文字幕一区二区三区有码在线看| 波多野结衣高清作品| 1024手机看黄色片| 国产色爽女视频免费观看| 久久久久国产精品人妻aⅴ院| 亚洲精品日韩在线中文字幕 | 色视频www国产| 亚洲av成人av| 69人妻影院| 卡戴珊不雅视频在线播放| 在线免费观看不下载黄p国产| 精品国内亚洲2022精品成人| 插逼视频在线观看| 一a级毛片在线观看| 俄罗斯特黄特色一大片| 日本撒尿小便嘘嘘汇集6| 国产探花在线观看一区二区| 伦理电影大哥的女人| 国产三级在线视频| 久久精品综合一区二区三区| 别揉我奶头~嗯~啊~动态视频| 特大巨黑吊av在线直播| 久久久久免费精品人妻一区二区| 亚洲美女黄片视频| 亚洲性夜色夜夜综合| 欧美zozozo另类| 免费大片18禁| 日韩欧美一区二区三区在线观看| 亚洲七黄色美女视频| 免费观看的影片在线观看| 亚洲av不卡在线观看| 久久久久国产精品人妻aⅴ院| 少妇人妻一区二区三区视频| 最近视频中文字幕2019在线8| 亚洲欧美中文字幕日韩二区| 九九爱精品视频在线观看| 丝袜美腿在线中文| 一级黄片播放器| 亚洲欧美日韩高清在线视频| 日韩av不卡免费在线播放| 亚洲性夜色夜夜综合| 非洲黑人性xxxx精品又粗又长| 看片在线看免费视频| 寂寞人妻少妇视频99o| 亚洲av.av天堂| 能在线免费观看的黄片| 欧美日本视频| 欧美日韩精品成人综合77777| 99国产精品一区二区蜜桃av| 成人鲁丝片一二三区免费| 99riav亚洲国产免费| 日韩三级伦理在线观看| 一级毛片久久久久久久久女| 国产69精品久久久久777片| 亚洲欧美成人精品一区二区| 中文字幕av成人在线电影| 亚洲内射少妇av| 国产麻豆成人av免费视频| 亚洲天堂国产精品一区在线| 免费观看在线日韩| 日本精品一区二区三区蜜桃| 最后的刺客免费高清国语| 国产色爽女视频免费观看| 悠悠久久av| 黄色视频,在线免费观看| 蜜桃亚洲精品一区二区三区| 婷婷精品国产亚洲av| 99久久精品热视频| 嫩草影院新地址| 在线免费观看不下载黄p国产| 天堂√8在线中文| 97人妻精品一区二区三区麻豆| 久久精品综合一区二区三区| 精品欧美国产一区二区三| 欧美绝顶高潮抽搐喷水| 我的老师免费观看完整版| 精品乱码久久久久久99久播| 日本一二三区视频观看| 又黄又爽又刺激的免费视频.| 黄色一级大片看看| 日韩精品有码人妻一区| 69av精品久久久久久| 亚洲久久久久久中文字幕| 婷婷亚洲欧美| 我的女老师完整版在线观看| 国产成人福利小说| 日本色播在线视频| 岛国在线免费视频观看| 国产91av在线免费观看| av专区在线播放| 日韩一本色道免费dvd| 欧美性猛交╳xxx乱大交人| 啦啦啦啦在线视频资源| 亚洲国产精品合色在线| 婷婷色综合大香蕉| 又粗又爽又猛毛片免费看| 免费无遮挡裸体视频| 黄片wwwwww| 给我免费播放毛片高清在线观看| 日韩成人伦理影院| 精品久久久久久久久亚洲| 嫩草影院精品99| 免费黄网站久久成人精品| 成人亚洲欧美一区二区av| 国产黄a三级三级三级人| 欧美xxxx性猛交bbbb| 国产伦在线观看视频一区| 免费电影在线观看免费观看| 99热全是精品| 日日摸夜夜添夜夜添av毛片| eeuss影院久久| 99riav亚洲国产免费| 秋霞在线观看毛片| 我要看日韩黄色一级片| 亚洲婷婷狠狠爱综合网| 国产高清三级在线| 国产精品一区二区性色av| 亚洲av第一区精品v没综合| 日韩欧美国产在线观看| 91久久精品电影网| 97在线视频观看| 久久草成人影院| 麻豆久久精品国产亚洲av| 99国产精品一区二区蜜桃av| 十八禁国产超污无遮挡网站| 精品熟女少妇av免费看| 丰满乱子伦码专区| 国产91av在线免费观看| 日本熟妇午夜| 黄片wwwwww| 69人妻影院| 乱码一卡2卡4卡精品| 日韩一本色道免费dvd| 美女内射精品一级片tv| 国产高清三级在线| 婷婷精品国产亚洲av在线| 男女之事视频高清在线观看| 欧美成人精品欧美一级黄| 成人无遮挡网站| 久久6这里有精品| 熟女人妻精品中文字幕| 91在线观看av| 亚洲精品日韩av片在线观看| 午夜免费激情av| 国产色爽女视频免费观看| 亚洲成人久久性| 色综合站精品国产| 亚洲一区高清亚洲精品| 国产成人a区在线观看| 亚洲aⅴ乱码一区二区在线播放| 级片在线观看| 人妻夜夜爽99麻豆av| 日韩成人av中文字幕在线观看 | 久久久欧美国产精品| 最好的美女福利视频网| 99九九线精品视频在线观看视频| 特大巨黑吊av在线直播| 伊人久久精品亚洲午夜| 欧美3d第一页| 中文字幕人妻熟人妻熟丝袜美| 插逼视频在线观看| 我要看日韩黄色一级片| 啦啦啦啦在线视频资源| 欧美日韩一区二区视频在线观看视频在线 | 久久人人爽人人片av| 久久久久国内视频| 成人综合一区亚洲| av国产免费在线观看| 国产亚洲av嫩草精品影院| 国产欧美日韩精品一区二区| 国产精品福利在线免费观看| 成人无遮挡网站| 日韩成人伦理影院| 国产精品免费一区二区三区在线| 熟女人妻精品中文字幕| 亚洲最大成人中文| 十八禁网站免费在线| 免费在线观看成人毛片| 网址你懂的国产日韩在线| 欧美性猛交黑人性爽| 极品教师在线视频| 我的老师免费观看完整版| 日日摸夜夜添夜夜爱| 亚洲三级黄色毛片| 3wmmmm亚洲av在线观看| 熟女人妻精品中文字幕| 两性午夜刺激爽爽歪歪视频在线观看| 亚洲av免费在线观看| 精品午夜福利在线看| 99在线人妻在线中文字幕| 一级黄片播放器| 日本黄大片高清| 亚洲国产精品成人综合色| 可以在线观看毛片的网站| eeuss影院久久| 99久久精品国产国产毛片| 欧洲精品卡2卡3卡4卡5卡区| 亚洲精品亚洲一区二区| 日本免费a在线| 国产精品久久电影中文字幕| 人妻夜夜爽99麻豆av| 欧美日韩乱码在线| 99久久久亚洲精品蜜臀av| 亚洲内射少妇av| 特大巨黑吊av在线直播| 国产精品久久久久久亚洲av鲁大| 狠狠狠狠99中文字幕| 久久草成人影院| 免费在线观看影片大全网站| 麻豆国产97在线/欧美| 成年女人毛片免费观看观看9| 久久久久国产网址| 在线观看一区二区三区| 好男人在线观看高清免费视频| 国产精品野战在线观看| 精品人妻视频免费看| 性色avwww在线观看| 伦精品一区二区三区| 久久久成人免费电影| 免费看av在线观看网站| 12—13女人毛片做爰片一| av卡一久久| 亚洲国产日韩欧美精品在线观看| 久久99热这里只有精品18| 国产精品久久久久久亚洲av鲁大| 美女免费视频网站| 亚洲成人久久爱视频| 一个人看的www免费观看视频| 九色成人免费人妻av| 国产淫片久久久久久久久| 国产精品国产高清国产av| 欧美一区二区国产精品久久精品| 99热这里只有精品一区| 欧美又色又爽又黄视频| 久久午夜福利片| 欧美绝顶高潮抽搐喷水| 淫秽高清视频在线观看| 天堂网av新在线| 91av网一区二区| av女优亚洲男人天堂| 亚洲最大成人中文| 又粗又爽又猛毛片免费看| 久久久午夜欧美精品| 日本一二三区视频观看| 黄色配什么色好看| 欧美性猛交╳xxx乱大交人| 午夜精品一区二区三区免费看| 日韩人妻高清精品专区| 国产精华一区二区三区| 少妇熟女aⅴ在线视频| 欧美一区二区国产精品久久精品| 最近最新中文字幕大全电影3| 男女啪啪激烈高潮av片| 精品久久久久久久久亚洲| 亚洲精品色激情综合| 精品99又大又爽又粗少妇毛片| 两个人的视频大全免费| 国内精品宾馆在线| 99久久久亚洲精品蜜臀av| 亚洲欧美日韩高清专用| 熟女电影av网| 一个人观看的视频www高清免费观看| 亚洲国产精品成人综合色| 久久精品夜色国产| 亚洲人成网站在线播放欧美日韩| 日本爱情动作片www.在线观看 | 日韩中字成人| 国产美女午夜福利| 午夜福利高清视频| 别揉我奶头~嗯~啊~动态视频| 国内少妇人妻偷人精品xxx网站| 给我免费播放毛片高清在线观看| 女同久久另类99精品国产91| 欧美zozozo另类| 久久久久国产网址| 少妇猛男粗大的猛烈进出视频 | 国产亚洲精品av在线| 我要看日韩黄色一级片| 中国美白少妇内射xxxbb| or卡值多少钱| 99精品在免费线老司机午夜| АⅤ资源中文在线天堂| 精品久久久久久久久久免费视频| 高清日韩中文字幕在线| 高清毛片免费看| 精品人妻视频免费看| 国产精品一二三区在线看| 国产精品久久久久久亚洲av鲁大| 插阴视频在线观看视频| 熟女电影av网| 国产精品久久视频播放| 亚洲最大成人中文| 欧美日韩乱码在线| 国产精品99久久久久久久久| 成人特级av手机在线观看| 国产欧美日韩精品一区二区| 变态另类丝袜制服| 亚洲丝袜综合中文字幕| 欧美精品国产亚洲| 99热精品在线国产| 久久久久久久久大av| 美女 人体艺术 gogo| 日韩 亚洲 欧美在线| 看十八女毛片水多多多| 91久久精品国产一区二区成人| 亚洲国产日韩欧美精品在线观看| 床上黄色一级片| 一本精品99久久精品77| 日韩欧美三级三区| 亚洲三级黄色毛片| a级毛片免费高清观看在线播放| 免费一级毛片在线播放高清视频| 亚洲最大成人av| 精品少妇黑人巨大在线播放 | 免费观看精品视频网站| 国产国拍精品亚洲av在线观看| 中文字幕久久专区| 久久人人爽人人爽人人片va| 一级毛片aaaaaa免费看小| 亚洲av免费在线观看| 亚洲第一电影网av| 草草在线视频免费看| 久久精品国产鲁丝片午夜精品| 3wmmmm亚洲av在线观看| 亚洲av不卡在线观看| 国产午夜精品久久久久久一区二区三区 | 一本一本综合久久| 不卡一级毛片| 99久国产av精品国产电影| 免费观看在线日韩| 午夜精品在线福利| 成人av一区二区三区在线看| 精品人妻熟女av久视频| 亚洲精品一区av在线观看| 免费看日本二区| 久久精品国产自在天天线| 成熟少妇高潮喷水视频| 亚洲综合色惰| 欧美高清性xxxxhd video| 久久久久精品国产欧美久久久| 人妻制服诱惑在线中文字幕| а√天堂www在线а√下载| 色综合色国产| 精品久久久久久久末码| 白带黄色成豆腐渣| 午夜免费激情av| 国产精品一区二区性色av| 熟女人妻精品中文字幕| av中文乱码字幕在线| 99热6这里只有精品| 国产一区二区三区av在线 | 欧美色视频一区免费| 国产成人精品久久久久久| 1024手机看黄色片| 国产乱人视频| 秋霞在线观看毛片| 亚洲激情五月婷婷啪啪| 免费在线观看成人毛片| av在线观看视频网站免费| 欧美3d第一页| www日本黄色视频网| 午夜福利成人在线免费观看| 精品国产三级普通话版| 乱码一卡2卡4卡精品| 亚洲熟妇中文字幕五十中出| 真人做人爱边吃奶动态| 偷拍熟女少妇极品色| 伦理电影大哥的女人| 99riav亚洲国产免费| 国产高潮美女av| 99热6这里只有精品| 美女大奶头视频| 国产精品永久免费网站| 日本精品一区二区三区蜜桃| 天堂av国产一区二区熟女人妻| 俄罗斯特黄特色一大片| 大香蕉久久网| 99riav亚洲国产免费| 一进一出抽搐gif免费好疼| 国产视频内射| 欧美日韩精品成人综合77777| 亚洲国产精品国产精品| 深夜精品福利| 亚洲精华国产精华液的使用体验 | 久久6这里有精品| 一个人看的www免费观看视频| 卡戴珊不雅视频在线播放| 亚洲国产精品合色在线| 亚洲成人精品中文字幕电影| 女生性感内裤真人,穿戴方法视频| 成人欧美大片| 最近视频中文字幕2019在线8| 欧美+日韩+精品| 男女视频在线观看网站免费| 久久精品91蜜桃| 能在线免费观看的黄片| av天堂在线播放| 免费黄网站久久成人精品| 国产亚洲91精品色在线| 97超碰精品成人国产| 99国产精品一区二区蜜桃av| 国产精品国产高清国产av| videossex国产| 日韩欧美 国产精品| 国产日本99.免费观看| 黄片wwwwww| 观看免费一级毛片| 色哟哟·www| 欧美日韩国产亚洲二区| 国产成人a∨麻豆精品| 国产极品精品免费视频能看的| 麻豆乱淫一区二区| 国产精品av视频在线免费观看| 精品久久久久久久久久免费视频| 淫秽高清视频在线观看| 免费无遮挡裸体视频| 1024手机看黄色片| 深夜a级毛片| 国产aⅴ精品一区二区三区波|